Alcon’s new intraocular lens for presbyopia receives FDA approval

Alcon, a leading eye care company, has announced that the US Food and Drug Administration (FDA) has approved the AcrySof IQ Vivity intraocular lens (IOL) for the treatment of presbyopia.

The AcrySof IQ Vivity IOL is a revolutionary new lens that can provide patients with a full range of clear vision, from near to far, without the need for glasses or contact lenses.

The lens is made of a unique material that allows it to change shape in response to changes in the eye’s natural focusing mechanism. This allows patients to see clearly at all distances, even in low-light conditions.

The AcrySof IQ Vivity IOL is the first and only IOL that has been approved by the FDA for the treatment of presbyopia. The lens is expected to be available to patients in the United States in early 2023.

“The approval of the AcrySof IQ Vivity IOL is a major milestone for Alcon and for patients who are looking for a solution to presbyopia,” said David J. Endicott, MD, president of Alcon’s Global Surgical Franchise.

“This lens has the potential to change the lives of millions of people who are struggling with the blurry vision that comes with presbyopia.”

What is presbyopia?

Presbyopia is a condition that affects people over the age of 40. It is caused by a gradual loss of elasticity in the lens of the eye. This makes it difficult to focus on near objects.

Symptoms of presbyopia include:

• Blurry vision at near distances
• Difficulty reading small print
• Needing more light to see clearly
• Eye strain or fatigue

How does the AcrySof IQ Vivity IOL work?

The AcrySof IQ Vivity IOL is a multifocal IOL that is designed to provide patients with a full range of clear vision, from near to far.

The lens is made of a unique material that allows it to change shape in response to changes in the eye’s natural focusing mechanism. This allows patients to see clearly at all distances, even in low-light conditions.

Benefits of the AcrySof IQ Vivity IOL

There are many benefits to choosing the AcrySof IQ Vivity IOL for the treatment of presbyopia. These benefits include:

• Clear vision at all distances, from near to far
• Reduced dependence on glasses or contact lenses
• Improved quality of life
• Increased independence

Who is a candidate for the AcrySof IQ Vivity IOL?

The AcrySof IQ Vivity IOL is an excellent option for patients who are over the age of 40 and who are experiencing symptoms of presbyopia.

The lens is also a good option for patients who are not satisfied with their current vision correction options, such as glasses or contact lenses.

How is the AcrySof IQ Vivity IOL implanted?

The AcrySof IQ Vivity IOL is implanted during a surgical procedure called cataract surgery. The surgery is typically performed on an outpatient basis, and it takes about 30 minutes to complete.

During the surgery, the surgeon will remove the cloudy natural lens of the eye and replace it with the AcrySof IQ Vivity IOL.

What is the recovery time for cataract surgery?

The recovery time for cataract surgery is typically about 2 weeks. During this time, patients will need to avoid strenuous activity and protect their eyes from bright light.

Most patients will experience significant improvement in their vision within a few days of surgery. However, it may take up to 6 weeks for the vision to fully stabilize.

Is the AcrySof IQ Vivity IOL right for me?

If you are over the age of 40 and you are experiencing symptoms of presbyopia, the AcrySof IQ Vivity IOL may be right for you.

To learn more about the AcrySof IQ Vivity IOL and to see if you are a candidate for the lens, talk to your eye doctor.